These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29144065)

  • 1. WHO Expert Committee on Drug Dependence.
    World Health Organization
    World Health Organ Tech Rep Ser; 2016; (998):1-34. PubMed ID: 29144065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHO Expert Committee on Drug Dependence. Thirty-sixth report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2015; (991):1-50, back cover. PubMed ID: 26062388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WHO Expert Committee on Drug Dependence.
    World Health Organization Expert Committee on Drug Dependence
    World Health Organ Tech Rep Ser; 2003; 915():i-v, 1-26, back cover. PubMed ID: 12772439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO Expert Committee On Drug Dependence.
    World Health Organ Tech Rep Ser; 1999; 887():1-23. PubMed ID: 10379231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WHO expert committee on drug dependence.
    World Health Organization
    World Health Organ Tech Rep Ser; 2012; (973):1-26. PubMed ID: 24547667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO Expert Committee on Drug Dependence.
    WHO Expert Committee on Drug Dependence
    World Health Organ Tech Rep Ser; 2006; (942):i, 1-21, 23-4 passim. PubMed ID: 17373571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO Expert Committee on Drug Dependence. Thirty-second report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2001; 903():i-v, 1-26. PubMed ID: 11851193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO expert committee on drug dependence.
    World Health Organ Tech Rep Ser; 1995; 856():1-17. PubMed ID: 8928523
    [No Abstract]   [Full Text] [Related]  

  • 9. WHO Expert Committee on drug dependence.
    World Health Organ Tech Rep Ser; 1991; 808():i-iv, 1-20. PubMed ID: 1677224
    [No Abstract]   [Full Text] [Related]  

  • 10. Exempt preparations: Historical perspectives.
    Harris LS
    Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S48-51. PubMed ID: 16529881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO Expert Committee on Drug Dependence. Twenty-sixth Report.
    World Health Organ Tech Rep Ser; 1989; 787():1-32. PubMed ID: 2555972
    [No Abstract]   [Full Text] [Related]  

  • 12. The World Health Organization's Expert Committee on drug dependence: comments on the 28th report (1994).
    Negrete JC
    Addiction; 1995 Nov; 90(11):1437-9. PubMed ID: 8528021
    [No Abstract]   [Full Text] [Related]  

  • 13. WHO Expert Committee on Drug Dependence. Thirtieth report.
    World Health Organ Tech Rep Ser; 1998; 873():i-vi, 1-50. PubMed ID: 9615607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principles of assessment of abuse liability: US legal framework and regulatory environment.
    Rocha BA
    Behav Pharmacol; 2013 Sep; 24(5-6):403-9. PubMed ID: 23820327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New psychoactive substances in Taiwan: The current situation and initiative for rational scheduling.
    Yu WJ; Cottler L; Li JH
    J Food Drug Anal; 2021 Mar; 29(1):168-181. PubMed ID: 35696229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scheduling of new psychoactive substance the Swiss way: A review and critical analysis.
    Grafinger KE; Bernhard W; Weinmann W
    Sci Justice; 2019 Jul; 59(4):459-466. PubMed ID: 31256819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Weighing the benefits and harms of psychotropic and analgesic substances - A perspective of German addiction medicine experts].
    Bonnet U; Specka M; Soyka M; Alberti T; Bender S; Hilger J; Hillemacher T; Kuhlmann T; Kuhn J; Lüdecke C; Reimer J; Schneider U; Schroeder W; Stuppe M; Wiesbeck G; Wodarz N; Scherbaum N
    Fortschr Neurol Psychiatr; 2022 Jan; 90(1-02):19-29. PubMed ID: 33634461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of tightening regulations on patients with new psychoactive substance-related disorders in Japan.
    Tanibuchi Y; Matsumoto T; Funada D; Shimane T
    Neuropsychopharmacol Rep; 2018 Dec; 38(4):189-196. PubMed ID: 30341809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modernizing methodology for the WHO assessment of substances for the international drug control conventions.
    Danenberg E; Sorge LA; Wieniawski W; Elliott S; Amato L; Scholten WK
    Drug Alcohol Depend; 2013 Aug; 131(3):175-81. PubMed ID: 23548737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convention on psychotropic substances, 1971. The role and responsibilities of the World Health Organization.
    Khan I
    Prog Neuropsychopharmacol; 1979; 3(1-3):11-4. PubMed ID: 400979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.